However, it is essential to follow the specific instructions provided by your healthcare provider, as they will take into consideration your unique medical history and overall health
doi:10.1172/JCI112855
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)
Because of their effectiveness and safety profile, GLP-1 treatments have become a popular option for individuals seeking medically guided weight management
Inhibition of carbohydrate-mediated glucagon-like peptide-I (736)amide secretion by circulating non-esterified fatty acids
If you have an employer plan, coverage for GLP-1 drugs can vary widely depending on the plan sponsor, insurer, the plan type, and the medical reason for prescribing the drug